Harold Bernstein

Business address
C/O Maze Therapeutics, Inc., 171 Oyster Point Boulevard, Suite 300, South San Francisco, CA, 94080
Top holdings (ownership)
MAZE
Get insider transactions for this reporting owner
Harold Bernstein has filed 2 SEC EDGAR filings since 30 Jan 2025

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing 24 Sep 2025 22 Sep 2025 001-42490
3 Open Document Open Filing 30 Jan 2025 30 Jan 2025 001-42490